Access the full text.
Sign up today, get DeepDyve free for 14 days.
J Liu, Q Wu, Y Hao, M Jiao, X Wang, S Jiang, L. Han (2021)
Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017, 36
RJ Norman, R Wu, MT. Stankiewicz (2004)
4: Polycystic ovary syndrome, 180
F Chiaffarino, S Cipriani, M Dalmartello, E Ricci, G Esposito, F Fedele, C La Vecchia, E Negri, F. Parazzini (2022)
Prevalence of polycystic ovary syndrome in European countries and USA: a systematic review and meta-analysis, 279
MA Charifson, BC. Trumble (2019)
Evolutionary origins of polycystic ovary syndrome: an environmental mismatch disorder, 2019
FR Day, DA Hinds, JY Tung, L Stolk, U Styrkarsdottir, R Saxena, A Bjonnes, L Broer, DB Dunger, BV Halldorsson (2015)
Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome, 6
F. Wei (2020)
A new era for evolutionary developmental biology in non-model organisms, 63
L Casarini, G. Brigante (2014)
The polycystic ovary syndrome evolutionary paradox: a genome-wide association studies-based, in silico, evolutionary explanation, 99
CR McCartney, JC. Marshall (2016)
CLINICAL PRACTICE. Polycystic ovary syndrome, 375
J Holte, T Bergh, C Berne, L Berglund, H. Lithell (1994)
Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance, 78
ME Teves, BP Modi, R Kulkarni, AX Han, JS Marks, MA Subler, J Windle, JM Newall, JM McAllister, JR. Strauss (2020)
Human DENND1A.V2 drives Cyp17a1 expression and androgen production in mouse ovaries and adrenals, 21
G Wang, JR. Speakman (2016)
Analysis of positive selection at single nucleotide polymorphisms associated with body mass index does not support the “thrifty gene” hypothesis, 24
R Azziz, DA Dumesic, MO. Goodarzi (2011)
Polycystic ovary syndrome: an ancient disorder?, 95
V Veikkolainen, N Ali, M Doroszko, A Kiviniemi, I Miinalainen, C Ohlsson, M Poutanen, N Rahman, K Elenius, SJ Vainio (2020)
Erbb4 regulates the oocyte microenvironment during folliculogenesis, 29
A Auton, GR Abecasis, DM Altshuler, RM Durbin, GR Abecasis, DR Bentley, A Chakravarti, AG Clark, P Donnelly, EE Eichler (2015)
A global reference for human genetic variation, 526
F Day, T Karaderi, MR Jones, C Meun, C He, A Drong, P Kraft, N Lin, H Huang, L Broer (2018)
Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria, 14
JM Vink, S Sadrzadeh, CB Lambalk, DI. Boomsma (2006)
Heritability of polycystic ovary syndrome in a Dutch twin-family study, 91
HF Escobar-Morreale, M Luque-Ramirez, MJ. San (2005)
The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome, 26
F. Tajima (1989)
Statistical method for testing the neutral mutation hypothesis by DNA polymorphism, 123
S Ge, YL. Guo (2020)
Evolution of genes and genomes in the genomics era, 63
H Chen, N Patterson, D. Reich (2010)
Population differentiation as a test for selective sweeps, 20
MG Hayes, M Urbanek, DA Ehrmann, LL Armstrong, JY Lee, R Sisk, T Karaderi, TM Barber, MI McCarthy, S Franks (2015)
Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations, 6
M. Przeworski (2002)
The signature of positive selection at randomly chosen loci, 160
M Dapas, F Lin, GN Nadkarni, R Sisk, RS Legro, M Urbanek, MG Hayes, A. Dunaif (2020)
Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis, 17
SJ Corbett, AJ McMichael, AM. Prentice (2009)
Type 2 diabetes, cardiovascular disease, and the evolutionary paradox of the polycystic ovary syndrome: a fertility first hypothesis, 21
RE Green, J Krause, AW Briggs, T Maricic, U Stenzel, M Kircher, N Patterson, H Li, W Zhai, MH-Y Fritz (2010)
A draft sequence of the Neandertal genome, 328
R Yang, Q Li, Z Zhou, W Qian, J Zhang, Z Wu, L Jin, X Wu, C Zhang, B Zheng (2022)
Changes in the prevalence of polycystic ovary syndrome in China over the past decade, 25
PC Sabeti, DE Reich, JM Higgins, HZ Levine, DJ Richter, SF Schaffner, SB Gabriel, JV Platko, NJ Patterson, GJ McDonald (2002)
Detecting recent positive selection in the human genome from haplotype structure, 419
ZJ Chen, H Zhao, L He, Y Shi, Y Qin, Y Shi, Z Li, L You, J Zhao, J Liu (2011)
Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3, 43
PC Sabeti, SF Schaffner, B Fry, J Lohmueller, P Varilly, O Shamovsky, A Palma, TS Mikkelsen, D Altshuler, ES. Lander (2006)
Positive natural selection in the human lineage, 312
H Lee, JY Oh, YA Sung, H Chung, HL Kim, GS Kim, YS Cho, JT. Kim (2015)
Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome, 30
Y Peng, W Zhang, P Yang, Y Tian, S Su, C Zhang, ZJ Chen, H. Zhao (2017)
ERBB4 confers risk for polycystic ovary syndrome in Han Chinese, 7
A Moraru, G Cakan-Akdogan, K Strassburger, M Males, S Mueller, M Jabs, M Muelleder, M Frejno, BP Braeckman, M Ralser (2017)
THADA regulates the organismal balance between energy storage and heat production, 41
J Yan, Y Tian, X Gao, L Cui, Y Ning, Y Cao, Y Chen, F Peng, L You, F Liu (2020)
A genome-wide association study identifies FSHR rs2300441 associated with follicle-stimulating hormone levels, 97
MJ Li, LY Wang, Z Xia, MP Wong, PC Sham, J. Wang (2014)
dbPSHP: a database of recent positive selection across human populations, 42
M Dapas, R Sisk, RS Legro, M Urbanek, A Dunaif, MG. Hayes (2019)
Family-based quantitative trait meta-analysis implicates rare noncoding variants in DENND1A in polycystic ovary syndrome, 104
JM McAllister, RS Legro, BP Modi, JR. Strauss (2015)
Functional genomics of PCOS: from GWAS to molecular mechanisms, 26
Y Zhang, K Ho, JM Keaton, DN Hartzel, F Day, AE Justice, NS Josyula, SA Pendergrass, K Actkins, LK Davis (2020)
A genome-wide association study of polycystic ovary syndrome identified from electronic health records, 223
R Azziz, LA Sanchez, ES Knochenhauer, C Moran, J Lazenby, KC Stephens, K Taylor, LR. Boots (2004)
Androgen excess in women: experience with over 1000 consecutive patients, 89
S Corbett, L. Morin-Papunen (2013)
The Polycystic Ovary Syndrome and recent human evolution, 373
SH Kim, M Liu, HS Jin, S. Park (2019)
High genetic risk scores of ASIC2, MACROD2, CHRM3, and C2orf83 genetic variants associated with polycystic ovary syndrome impair insulin sensitivity and interact with energy intake in Korean women, 84
KS Ruth, FR Day, J Tyrrell, DJ Thompson, AR Wood, A Mahajan, RN Beaumont, L Wittemans, S Martin, AS Busch (2020)
Using human genetics to understand the disease impacts of testosterone in men and women, 26
Y Shi, H Zhao, Y Shi, Y Cao, D Yang, Z Li, B Zhang, X Liang, T Li, J Chen (2012)
Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome, 44
E Diamanti-Kandarakis, A. Dunaif (2012)
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications, 33
JN Sampson, KK Kidd, JR Kidd, H. Zhao (2011)
Selecting SNPs to identify ancestry, 75
KE Holsinger, BS. Weir (2009)
Genetics in geographically structured populations: defining, estimating and interpreting F(ST), 10
NS Kakoly, A Earnest, HJ Teede, LJ Moran, AE. Joham (2019)
The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome, 42
Y Yao, J Yang, Y Xie, H Liao, B Yang, Q Xu, S. Rao (2020)
No evidence for widespread positive selection signatures in common risk alleles associated with schizophrenia, 46
S Franks, S Robinson, DS. Willis (1996)
Nutrition, insulin and polycystic ovary syndrome, 1
STUDY QUESTIONWas polycystic ovary syndrome (PCOS), which impairs fertility and adheres to the evolutionary paradox, subject to evolutionary selection during ancestral times and did rapidly diminish in prevalence?SUMMARY ANSWERThis study strengthened the hypothesis that positive selection of genetic variants occurred and may account for the high prevalence of PCOS observed today.WHAT IS KNOWN ALREADYPCOS is a complex endocrine disorder characterized by both reproductive and metabolic disturbances. As a heritable disease that impairs fertility, PCOS should diminish rapidly in prevalence; however, it is the most common cause of female subfertility globally. Few scientific genetic studies have attempted to provide evidence for the positive selection of gene variants underlying PCOS.STUDY DESIGN, SIZE, DURATIONWe performed an evolutionary analysis of 2,504 individuals from 14 populations of the 1000 Genomes Project.PARTICIPANTS/MATERIALS, SETTING, METHODSWe tested the signature of positive selection for 37 single-nucleotide polymorphisms (SNPs) associated with PCOS in previous genome-wide association studies using six parameters of positive selection.MAIN RESULTS AND THE ROLE OF CHANCEAnalyzing the evolutionary indices together, there was obvious positive selection at the PCOS-related SNPs loci, especially within the original evolution window of humans, demonstrated by significant Tajima’s D values. Compared to the genome background, six of the 37 SNPs in or close to five genes (DENN domain-containing protein 1A: DENND1A, chromosome 9 open reading frame 3: AOPEP, aminopeptidase O: THADA, diacylglycerol kinase iota: DGKI, and netrin receptor UNC5C: UNC5C) showed significant evidence of positive selection, among which DENND1A, AOPEP, and THADA represent the set of most established susceptibility genes for PCOS.LIMITATIONS, REASONS FOR CAUTIONFirst, only well-documented SNPs were selected from well-designed experiments. Second, it is difficult to determine which hypothesis of PCOS evolution is at play. After considering the most significant functions of these genes, we found that they had a wide variety of functions with no obvious association between them.WIDER IMPLICATIONS OF THE FINDINGSOur findings provide additional evidence for the positive evolution of PCOS. Our analyses require confirmation in a larger study with more evolutionary indicators and larger data range. Further research to identify the roles of the DENND1A, AOPEP, THADA, DGKI, and UNC5C genes is also necessary.STUDY FUNDING/COMPETING INTEREST(S)This study was supported by the National Key Research and Development Program of China (2021YFC2700400 and 2021YFC2700701), Basic Science Center Program of NSFC (31988101), CAMS Innovation Fund for Medical Sciences (2021-I2M-5-001), National Natural Science Foundation of China (82192874, 31871509, and 82071606), Shandong Provincial Key Research and Development Program (2020ZLYS02), Taishan Scholars Program of Shandong Province (ts20190988), and Fundamental Research Funds of Shandong University. The authors have no conflicts of interest to disclose.TRIAL REGISTRATION NUMBERN/A.
Human Reproduction – Oxford University Press
Published: Nov 20, 2023
Keywords: aminopeptidase O; DENN domain-containing protein 1A; evolution; evolutionary paradox; genome-wide association studies; PCOS; positive selection; single-nucleotide polymorphism; the 1000 Genomes Project; thyroid adenoma-associated protein
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.